Home World News Zenocutuzumab Shows Efficacy in Patients with Advanced NRG1 Fusion-positive Cancers World News Zenocutuzumab Shows Efficacy in Patients with Advanced NRG1 Fusion-positive Cancers By Ogkologos - February 19, 2025 928 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the eNRGy study Source RELATED ARTICLESMORE FROM AUTHOR Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR ESMO Urges EU Policymakers to Protect the Wellbeing of the Oncology... September 10, 2025 FDA Approves Injectable Nivolumab, an Alternative to IV Infusion February 19, 2025 Carriers of a Germline Pathogenic Variant in CDKN2A are at a... June 17, 2022 Stressed out – the cancer cells that survive chemotherapy, but at... April 29, 2021 Load more HOT NEWS ER-Low Positive Breast Cancer Shows Similar Clinical Behaviour and Response to... Grabbing the Perfect Gift Genomic Alterations Enriched in Young Women with HR-positive, HER2-negative Early Breast... Qué debo saber sobre los programas de emparejamiento de ensayos clínicos...
